Prophylactic treatment of migraine

Journal of Headache and Pain

Volumn 2, Issue 3, 2001, Pages 147-161

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ACETYLSALICYLIC ACID; ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; ERGOTAMINE DERIVATIVE; FLUNARIZINE; GABAPENTIN; GUANFACINE; METHYSERGIDE; MONOAMINE OXIDASE INHIBITOR; NADOLOL; NIFEDIPINE; NORTRIPTYLINE; PIZOTIFEN; PLACEBO; SEROTONIN; SEROTONIN 1 ANTAGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN ANTAGONIST; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VERAPAMIL; WARFARIN;

ASTHENIA; COGNITIVE DEFECT; CONSTIPATION; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DIET; DROWSINESS; DRUG EFFICACY; DRUG EXCRETION; DRUG FORMULATION; DRUG INDICATION; ENDOCRINE DISEASE; ENVIRONMENTAL FACTOR; FATIGUE; FETUS RISK; FOOD DRUG INTERACTION; FOOD PREFERENCE; HEADACHE; HUMAN; HYPERTENSION; MIGRAINE; PATIENT COMPLIANCE; PRIMARY PREVENTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RASH; REVIEW; SEDATION; STOMACH DISEASE; TREMOR; WEIGHT GAIN;

EID: 0035733680     PISSN: 11292369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (165)

1. General principles of pharmacological treatment
2. Drug treatment for the prevention of migraine headache
3. Chronic daily headache
4. Relationships between food, wine, and beer-precipitated migrainous headaches
5. Toward a rational understanding of migraine trigger factors
6. Propranolol in prophylaxis of migraine
7. Prophylactic treatment of migraine with propranolol. A clinical trial
8. No clearcut long-term prophylactic effect of one month of treatment with propranolol in migraineurs
9. Propranolol for migraine prophylaxis
10. Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis
11. Prophylactic treatment of migraine with tolfenamic acid, propranolol and placebo
12. Propranolol and migraine. A clinical trial
13. Long-acting propranolol in migraine prophylaxis: Results of a double-blind, placebo-controlled study
14. Propranolol in the management of recurrent migraine: A meta-analytic review
15. Short-term clinical trial of propranolol in racemic form (Inderal), D-propranolol, and placebo in migraine
16. Timolol vs. propranolol vs. placebo in common migraine prophylaxis: A double-blind multicenter trial
17. Cyclandelate versus propranolol in the prophylaxis of migraine - A double-blind placebo-controlled study
18. Comparison of propranolol LA 80 mg and propranolol LA 160 mg in migraine prophylaxis: A placebo-controlled study
19. Long-acting propranolol in the prophylaxis of migraine: A comparative study of two doses
20. Long-acting propranolol in the prophylaxis of migraine: Comparison of the daily doses of 80 mg and 160 mg
21. Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine
22. Flunarizine vs. propranolol in the prophylaxis of migraine: Two double-blind comparative studies in more than 400 patients
23. Flunarizine and propranolol in the treatment of migraine
24. A comparative trial of flunarizine and propranolol in the prevention of migraine
25. A double-blind controlled study of propranolol and cyproheptadine in migraine prophylaxis
26. Prophylaxis of migraine and mixed headache. A randomized controlled study
27. Selective and non-selective beta-blockers: Are both effective in prophylaxis of migraine? A clinical trial versus methysergide
28. Tolfenamic acid versus propranolol in the prophylactic treatment of migraine
29. A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura
30. Propranolol in the treatment of migraine
31. Prophylactic treatment of classical and non-classical migraine with metoprolol: A comparison with placebo
32. Propranolol vs flunarizine vs flunarizine plus propranolol in migraine without aura prophylaxis. A double-blind trial
33. Metoprolol and propranolol in the prophylactic treatment of classical and common migraine. A double-blind study
34. Metoprolol and propranolol in migraine prophylaxis: A double-blind multicentre study
35. Comparative study of nadolol and propranolol in prophylactic treatment of migraine
36. Propranolol in prophylaxis of migraine
37. Nadolol and propranolol in migraine management
38. Behavioral and physical treatments for migraine headache
39. Clinical trial of LB-46 (d, 1-4-(2-hydroxy-3-isopropyl-aminopropoxy) indol. An adrenergic beta-receptor blocking agent in migraine prophylaxis
40. Prophylactic treatment of migraine with long acting propranolol. A comparison with placebo
41. Verapamil and propranolol in migraine prophylaxis: A double-blind crossover study
42. Atenolol for migraine prophylaxis
43. Atenolol in migraine prophylaxis: A double-blind cross-over multicentre study
44. Nadolol and placebo comparison study in the prophylactic treatment of migraine
45. Nadolol: Its use in the prophylactic treatment of migraine
46. Comparative efficacy of nadolol and propranolol in the management of migraine
47. Nadolol and placebo comparison study in the prophylactic treatment of migraine
48. Clomipramine and metoprolol in migraine prophylaxis - A double-blind crossover study
49. Study Group A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study
50. Classic migraine: Effective prophylaxis with metoprolol
51. Metoprolol in the prophylaxis of migraine: Parallel-groups comparison with placebo and dose-ranging follow-up
52. Propranolol in the treatment of migraine
53. Migraine prevention with timolol. A double-blind crossover study
54. The prevention of migraine: A critical review with special emphasis on beta-adrenoceptor blockers
55. Metoprolol and pizotifen in the prophylactic treatment of classical and common migraine. A double-blind investigation
56. Flunarizine in migraine: A double-blind placebo-controlled study (in a Saudi population)
57. A double-blind placebo-controlled prophylactic study of flunarizine (Sibelium) in migraine
58. Flunarizine in the prevention of classical migraine: A placebo-controlled evaluation
59. Influence of flunarizine on the altered electronystagmographic (ENG) recordings in migraine
60. A placebo-controlled, double-blind, cross-over trial of flunarizine in common migraine
61. Flunarizine in migraine prophylaxis: An Indian trial
62. Alpha-dihydroergocryptine in the prophylaxis of migraine: A multicenter double-blind study versus flunarizine
63. Flunarizine versus metoprolol in migraine prophylaxis: A double-blind, randomized parallel group study of efficacy and tolerability
64. Metoprolol versus flunarizine: A double-blind cross-over study
65. Flunarizine-pizotifen single-dose double-blind cross-over trial in migraine prophylaxis
66. Comparison of flunarizine (Sibelium) and pizotifen (Sandomigran) in migraine treatment: A double-blind study
67. Flunarizine versus pizotifen: A double-blind study in the prophylaxis of migraine
68. Dihydroergokryptine vs. flunarizine in the basic treatment of migraine without aura
69. Nimodipine versus flunarizine in common migraine: A controlled pilot trial
70. Comparison of the efficacy between flunarizine and nifedipine in the prophylaxis of migraine
71. Comparative efficacy of cyclandelate versus flunarizine in the prophylactic treatment of migraine
72. Flunarizine in migraine prophylaxis: Predictive factors for a positive response
73. Verapamil in prophylactic therapy of migraine
74. Verapamil prophylaxis of migraine: A double-blind, placebo-controlled study
75. Nimodipine in migraine prophylaxis
76. European multicenter trial of nimodipine in the prophylaxis of classic migraine (migraine with aura)
77. Nimodipine, a new calcium antagonist in the prophylactic treatment of migraine
78. Efficacy of nimodipine in the prophylaxis of migraine
79. Nifedipine in the prophylaxis of classic migraine: A crossover, double-masked, placebo-controlled study of headache frequency and side effects
80. Nifedipine in migraine and tension headache: A randomized double-blind crossover study
81. Responders and non-responders to metoprolol, propranolol and nifedipine treatment in migraine prophylaxis: A dose-range study based on time-series analysis
82. Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone
83. Efficacy and tolerance of cyclandelate versus pizotifen in the prophylaxis of migraine
84. Flunarizine vs. pizotifen in migraine prophylaxis: A review of comparative studies
85. Methysergide
86. Migraine and depression: Effect of amitriptyline prophylaxis
87. Amitriptyline in migraine prophylaxis
88. Amitriptyline in migraine prophylaxis. Changes in pattern of attacks during a controlled clinical trial
89. Migraine prophylaxis. A comparison of propranolol and amitriptyline
90. Timed-release dihydroergotamine in the prophylaxis of mixed headache. A study versus amitriptyline
91. Fluoxetine prophylaxis of migraine
92. Double-blind trial of fluoxetine: Chronic daily headache and migraine
93. S-fluoxetine in the prophylaxis of migraine: A phase II double-blind randomized placebo-controlled study
94. A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis
95. Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension-type headaches
96. Propranolol and femoxetine, a HT-uptake inhibitor, in migraine prophylaxis. A double-blind crossover study
97. Femoxetine - A new 5-HT uptake inhibitor - And propranolol in the prophylactic treatment of migraine
98. Double-blind trial of clonidine in the treatment of migraine in a general practice
99. Clonidine in the prophylaxis of migraine
100. Efficacy of transdermal clonidine for headache prophylaxis and reduction of narcotic use in migraine patients. A randomized crossover trial
101. Clonidine in prophylaxis of migraine
102. Clonidine in migraine prophylaxis
103. Prophylactic treatment of migraine with clonidine. A controlled clinical trial
104. Double-blind study of clonidine and placebo for the prophylactic treatment of migraine
105. Evaluation of clonidine in prophylaxis of migraine. Double-blind trial and follow-up
106. 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155 or Catapresan) as a prophylactic remedy against migraine
107. Clonidine (Catapresan)-double-blind study after long-term treatment with the drug in migraine
108. Preliminary report on the use of clonidine (Boehringer Ingelheim) in the treatment of migraine
109. Metoprolol vs. clonidine in the prophylactic treatment of migraine
110. Propranolol (Inderal) and clonidine (Catapressan) in the prophylactic treatment of migraine. A comparative trial
111. No authors listed. Clonidine in migraine prophylaxis - Now obsolete
112. Prophylactic treatment for migraine: A comparison of pizotifen and clonidine
113. Efficacy of guanfacine in a double-blind parallel study for migraine prophylaxis
114. An open label cross-over comparison of divalproex sodium and propranolol HCl in the prevention of migraine headaches
115. Divalproex sodium in migraine prophylaxis: A dose-controlled study
116. Valproic acid is effective in migraine prophylaxis at low serum levels: A prospective open-label study
117. Migraine prophylaxis with divalproex
118. Efficacy of gabapentin in migraine prophylaxis
119. Sodium valproate has a prophylactic effect in migraine without aura: A triple-blind, placebo-controlled crossover study
120. Preliminary results of a double-blind study with the new migraine prophylactic drug gabapentin
121. Gabapentin in the prophylaxis of migraine: A double-blind randomized placebo-controlled study
122. Prophylactic treatment of episodic migraine with topiramate: A double-blind, placebo-controlled trial in 30 patients
123. A double-blind, randomized, placebo controlled, parallel study to determine the efficacy of topamax (Topiramate) in the prophylaxis of migraine
124. Use of topiramate as prophylactic treatment in migraine: Result of a pilot study
125. Efficacy of topiramate in migraine prophylaxis: A retrospective chart analysis
126. The effect of topiramate on weight in chronic daily headache and episodic migraine patients
127. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura
128. Effectiveness of lamotrigine in the prophylaxis of migraine with aura: An open pilot study
129. Lamotrigine in the prophylactic treatment of migraine aura - A pilot study
130. Aetiology of migraine and prevention with carbamazepine (Tegretol): Results of a double-blind, cross-over study
131. A comparative trial of prindolol, clonidine and carbamazepine in the interval therapy of migraine
132. Aspirin prophylaxis in migraine
133. Migraine prophylaxis: A new approach
134. Platelet antagonists in migraine prophylaxis. A clinical trial using aspirin and dipyridamole
135. Fenoprofen in migraine prophylaxis
136. Fenoprofen in the prophylaxis of migraine: A double-blind, placebo-controlled study
137. Flurbiprofen in the prophylaxis of migraine
138. Lornoxicam, a new non-steroidal anti-inflammatory drug in migraine prophylaxis: A double blind multicentric study
139. A double-blind placebo-controlled trial of indobufen in the prophylaxis of migraine
140. Clinical trial of a new antibradykinin, anti-inflammatory drug, ketoprofen (19.583 r.p.) in migraine prophylaxis
141. A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache
142. A comparative study of naproxen sodium, pizotyline and placebo in migraine prophylaxis
143. Naproxen in the prevention of migraine attacks: A double-blind placebo-controlled cross-over study
144. Naproxen in prophylaxis in migraine
145. Naproxen sodium in menstrual migraine prophylaxis: A double-blind placebo controlled study
146. Prophylactic effect of naproxen sodium on perimenstrual headache: A double-blind placebo controlled study
147. Successful migraine prophylaxis with naproxen sodium
148. Variability in risk of gastrointestinal complications with different nonsteroidal anti-inflammatory drugs
149. Meta-analysis of risk of gastrointestinal complications with NSAIDs. Authors should not have included data from one study
150. Combined low-dose acetylsalicylic acid and dihydroergotamine in migraine prophylaxis. A double-blind, placebo-controlled crossover study
151. Preventive treatment of headache with slow-release dihydroergotamine: Comparison of dosage protocols
152. Dihydroergokryptine versus dihydroergotamine in migraine prophylaxis: A double-blind clinical trial
153. Lisuride for the prevention of migraine. Results of a multicenter study
154. A practical guide to the management and prevention of migraine
155. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial
156. Prevention of menstrual migraine by percutaneous oestradiol
157. Migraine associated with menstruation
158. Efficacy of feverfew as prophylactic treatment of migraine
159. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
160. Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: A double-blind placebo-controlled study
161. Herbal medicines in migraine prevention: Randomized double-blind placebo-controlled crossover trial of feverfew preparation
162. Prophylaxis of migraine with oral magnesium: Results from a prospective, multi-center, placebo-controlled and double-blind randomized study
163. Magnesium in the prophylaxis of migraine - A double-blind placebo-controlled study
164. Magnesium prophylaxis of menstrual migraine: Effects on intracellular magnesium